Insiders who reported open-market trades in the last 12 months at the companies Kenneth Bate files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
Mardi Dier - $3.77M in MDGL purchases and sales in the last 12 months
Carole Huntsman - $1.71M in MDGL purchases and sales in the last 12 months
Rebecca Taub - $1.63M in MDGL purchases and sales in the last 12 months
David Soergel - $952K in MDGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Kenneth Bate is a corporate insider of Astria Therapeutics, Inc. (ATXS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kenneth Bate last file a Form 4?
The most recent primary Form 4 on record is dated 23 January 2026, one of 5 filings going back to 2025.
Has Kenneth Bate been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($11.68M) across all tracked filings.
Kenneth Bate files SEC Form 4 reports at Astria Therapeutics, Inc. (ATXS). 5 SEC Form 4 filings on record going back to 2025, most recently on 23 January 2026. Most recent open-market trade: sold $15K of MDGL on 7 November 2025. Lifetime open-market sales: $11.68M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Kenneth Bate.
InsiderAlpha's records for Kenneth Bate go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
